卡卡丁衍生物的制备及其抗瘤活性

Yu-Ying Jiang1,2, Hui-Hua Dong1,2, Wen-Ting Zhou1,2

  • 1Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China.

概括

一种新型的kakkatin衍生品,HK,通过抑制细胞增殖,入侵和转移,对肝细胞癌 (HCC) 具有强大的抗瘤活性. 这种衍生物可以作为治疗HCC的有希望的主要药物,向PDE3B和NFKB1蛋白质.